Bristol-Myers Squibb Company PFD CONV 2

PINK:BMYMP USA Other
Market Cap
$9.70 Million
Market Cap Rank
#28777 Global
#9570 in USA
Share Price
$1003.20
Change (1 day)
+0.00%
52-Week Range
$975.00 - $1013.80
All Time High
$1986.37
About

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. The company offers drugs in various therapeutic classes, such as oncology; cardiovascular; immunoscience; and virology, including human immunodeficiency virus (HIV) infection. Its products include Opdivo, a biological product for anti-cancer indications; Eliquis… Read more

Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) - Total Liabilities

Latest total liabilities as of September 2024: $76.47 Billion USD

Based on the latest financial reports, Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) has total liabilities worth $76.47 Billion USD as of September 2024.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Bristol-Myers Squibb Company PFD CONV 2 - Total Liabilities Trend (1987–2023)

This chart illustrates how Bristol-Myers Squibb Company PFD CONV 2's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Bristol-Myers Squibb Company PFD CONV 2 Competitors by Total Liabilities

The table below lists competitors of Bristol-Myers Squibb Company PFD CONV 2 ranked by their total liabilities.

Company Country Total Liabilities
Wing Yip Food (China) Holdings Group Limited
KQ:900340
Korea ₩42.79 Million
PCF Group SA
WAR:PCF
Poland zł107.73 Million
GTL Limited
NSE:GTL
India ₹62.02 Billion
A1 Investments & Resources Ltd
AU:AYI
Australia AU$317.73K
Farminveste, S.G.P.S., S.A.
LS:MLFMV
Portugal €448.75 Million
Venus Metals Corporation Ltd
AU:VMC
Australia AU$353.13K
Q Capital Partners Co. Ltd
KQ:016600
Korea ₩44.56 Billion

Liability Composition Analysis (1987–2023)

This chart breaks down Bristol-Myers Squibb Company PFD CONV 2's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.24 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 4.46 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.82 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bristol-Myers Squibb Company PFD CONV 2's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bristol-Myers Squibb Company PFD CONV 2 (1987–2023)

The table below shows the annual total liabilities of Bristol-Myers Squibb Company PFD CONV 2 from 1987 to 2023.

Year Total Liabilities Change
2023-12-31 $65.67 Billion -0.04%
2022-12-31 $65.70 Billion -10.38%
2021-12-31 $73.31 Billion -9.05%
2020-12-31 $80.60 Billion +3.01%
2019-12-31 $78.25 Billion +964.72%
2018-12-31 $7.35 Billion -66.14%
2017-12-31 $21.70 Billion +25.02%
2016-12-31 $17.36 Billion +0.21%
2015-12-31 $17.32 Billion -7.68%
2014-12-31 $18.77 Billion -19.65%
2013-12-31 $23.36 Billion +4.93%
2012-12-31 $22.26 Billion +30.15%
2011-12-31 $17.10 Billion +10.79%
2010-12-31 $15.44 Billion -4.84%
2009-12-31 $16.22 Billion -6.29%
2008-12-31 $17.31 Billion +10.90%
2007-12-31 $15.61 Billion +0.17%
2006-12-31 $15.58 Billion -7.95%
2005-12-31 $16.93 Billion -16.32%
2004-12-31 $20.23 Billion +14.41%
2003-12-31 $17.68 Billion +11.18%
2002-12-31 $15.91 Billion -2.54%
2001-12-31 $16.32 Billion +94.34%
2000-12-31 $8.40 Billion -0.84%
1999-12-31 $8.47 Billion -2.61%
1998-12-31 $8.70 Billion +12.09%
1997-12-31 $7.76 Billion -4.40%
1996-12-31 $8.12 Billion +0.10%
1995-12-31 $8.11 Billion +12.50%
1994-12-31 $7.21 Billion +16.96%
1993-12-31 $6.16 Billion +28.78%
1992-12-31 $4.78 Billion +32.12%
1991-12-31 $3.62 Billion -4.64%
1990-12-31 $3.80 Billion +11.25%
1989-12-31 $3.41 Billion +2.65%
1988-12-31 $3.33 Billion +20.51%
1987-12-31 $2.76 Billion --